Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 548.28 M

Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 548.28 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 15.28% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 475.59 M, a 32.44% change year over year.
  • Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 359.11 M, a 60.12% change year over year.
  • Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 224.27 M, a 59.37% change year over year.
  • Inspire Medical Systems, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 140.73 M, a 40.80% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue